Salute e Benessere

Avalere Health taps Sarah Hall, FCB Health New York vet, as President of US…

In this pivotal role, Hall will lead Avalere Health's US Marketing Agency of Record teams in an era of deep creativity and digital innovation, including its Creative and Media offerings as well as Access Marketing and Learning and Development. She will further a vision for the future of US Marketing that ensures biopharmaceutical and healthcare technology clients stay ahead in a complex and political environment, building meaningful, compelling, authentic engagements that reach every patient…
PR Newswire
04/12/2025

Intracardiac Echocardiography Devices Market to Reach $621.3 Million, Globally…

Market Introduction Market Introduction Intracardiac echocardiography (ICE) devices are advanced imaging tools used to provide real-time, high-resolution ultrasound images from within the heart. These devices enable precise visualization of cardiac structures during interventional procedures such as catheter ablation, valve repair, and closure of cardiac defects. The ICE market has witnessed significant growth due to increasing prevalence of cardiovascular diseases and rising demand for...
PR Newswire
04/12/2025

Cleanroom Technologies Market Surges Toward US$10.58 Billion by 2031, Driven by…

Clean room facilities have become indispensable as global industries move toward precision manufacturing, nanotechnology, biologics, and injectable therapies. In 2024, demand accelerated sharply as the U.S., Japan, South Korea, Taiwan, and the EU expanded chip fabrication programs, while pharmaceutical companies scaled up sterile injectables, mRNA production, and gene therapy fill-finish operations. Clean room facilities have become indispensable as global industries move toward precision...
PR Newswire
04/12/2025

LILYSILK's SILKERRY™ Collection Named Double Grand Winner at 2025 International…

"This season's winners show how luxury continues to evolve while remaining rooted in quality and presence," said Thomas Brandt, spokesperson of the IAA. "We are proud to celebrate the success of LILYSILK this year, as they continue to exceed expectations while the award remains the definitive platform for the world's most accomplished luxury designers and brands." "This season's winners show how luxury continues to evolve while remaining rooted in quality and…
PR Newswire
04/12/2025

Quotient Sciences and Intrepid Labs form strategic partnership to accelerate…

ANDROMEDA supports rapid exploration of formulation options, helping reduce experimental burden, minimize drug substance demands, and enhance data-driven decision making. It uses an advanced, proprietary machine learning algorithm, not a large language model, and has the potential for client-specific or aggregated multi-client models for enhanced predictivity. ANDROMEDA supports rapid exploration of formulation options, helping reduce experimental burden, minimize drug substance demands, and...
PR Newswire
04/12/2025

LuxAI, Luxembourg Institute of Health, and University of Birmingham launch the…

This international collaboration marks a major milestone in early-years support for autistic children and digital health innovation, evaluating how socially assistive robots can enhance the accessibility and quality of early developmental support for both children and their parents. This international collaboration marks a major milestone in early-years support for autistic children and digital health innovation, evaluating how socially assistive robots can enhance the accessibility and…
PR Newswire
04/12/2025

Renuka Iyer, MD, Named New Chief Medical Officer for National Comprehensive…

Dr. Iyer has a long history of leadership and innovation in oncology. She currently serves as a Professor of Oncology for Roswell Park Comprehensive Cancer Center—one of NCCN's Member Institutions—as well as Section Chief of Gastrointestinal Oncology and Vice Chair of Faculty Affairs in Roswell Park's Department of Medicine, and Medical Director for Medical Oncology across the Roswell Park Care Network. She also serves as a Professor of Medicine at Jacobs School of Medicine at the University of…
PR Newswire
04/12/2025

Lappset awarded Nordic Swan Ecolabel for its consistent commitment to…

Industrial News Service
04/12/2025

Change negotiations completed at Bioretec

The negotiations began on November 19, 2025, and were concluded today. The negotiations began onNovember 19, 2025, and were concluded today. At the start of the negotiations, the company estimated that the plans may impact the terms of employment of up to eight employees inFinland. As a result of the negotiations, the employment of two employees will be terminated, and five production employees will be temporarily laid off. In addition, the job description of one employee will undergo...
PR Newswire
04/12/2025

Generic Injectables Market Dominated by Hospital Pharmacies with 61.23% Share as…

Market Growth Drivers Market Growth Drivers Segmentation Insights The generic injectables market is segmented by molecule type, product type, route of administration, therapeutic area, distribution channel, and geography. By Product Type By Molecule Type By Therapeutic Area By Route of Administration By Distribution Channel To know more about the segments driving the market growth, visit - ...
PR Newswire
04/12/2025

Formycon and MS Pharma sign exclusive commercialization partnership for…

"This licensing deal for the MENA region represents the start of the commercial partnering activities for our Keytruda ®biosimilar candidate. Further agreements for additional regions and countries shall follow in due time. With MS Pharma, we are leveraging the well-established excellent collaboration that has already been successfully implemented for our biosimilars FYB201, FYB202, and FYB203. MS Pharma is a strong player that can sustainably improve access to this important cancer...
PR Newswire
04/12/2025

Cumulus Neuroscience Presents Data at CTAD 2025 Annual Meeting

Cumulus presented a poster titled, "Validating a Multi-Domain Digital Endpoint Platform (NeuLogiq) for Decentralized Alzheimer's Trials: Results from the CNS-101 Study," which confirms the superior sensitivity and statistical power of its proprietary NeuLogiq Platform compared to current industry benchmarks. Cumulus presented a poster titled, "Validating a Multi-Domain Digital Endpoint Platform (NeuLogiq) for Decentralized Alzheimer's Trials: Results from the CNS-101 Study,"…
PR Newswire
04/12/2025

'CART BP' Demonstrates Successful Blood Pressure Monitoring in Microgravity

The experiment was conducted by a research team from the University of Cambridge (UK) in collaboration with the International Institute of Astronautical Sciences (IIAS). The experiment was conducted by a research team from theUniversity of Cambridge(UK) in collaboration with the International Institute of Astronautical Sciences (IIAS). The IIAS-02 mission took place in a microgravity environment generated during parabolic flight, where apparent gravity approaches zero following a steep...
PR Newswire
04/12/2025

iOnctura initiates Phase I/II trial in patients with myelofibrosis ahead of new…

The Phase I/II trial is part of a comprehensive development program evaluating next-generation PI3Kδ inhibitor roginolisib's tolerability and anti-tumor response across a number of solid and hematologic malignancies. The Phase I/II trial is part of a comprehensive development program evaluating next-generation PI3Kδ inhibitor roginolisib's tolerability and anti-tumor response across a number of solid and hematologic malignancies. "Based on non-clinical data being presented at ASH, we...
PR Newswire
04/12/2025

Swedish health care region expands with Sectra and digitizes pathology for…

Region Halland has used Sectra's solutions within its radiology and breast imaging workflows for several years. Following this new addition, they will begin using Sectra's digital pathology module to further enhance their pathology workflows. Digital pathology brings numerous advantages for hospitals, pathologists, and patients alike. With Sectra's solution, Region Halland will gain a vendor-neutral and scalable system that strengthens data security and reduces time spent on manual processes…
PR Newswire
04/12/2025

The New England Journal of Medicine Publishes Positive Phase 3 VALIANT Results…

The data published in NEJM highlights the positive Phase 3 VALIANT results at Week 26, which were consistent across patients with C3G and primary IC-MPGN, adolescents and adults, and native and post-transplant kidney disease. The data published in NEJM highlights the positive Phase 3 VALIANT results at Week 26, which were consistent across patients with C3G and primary IC-MPGN, adolescents and adults, and native and post-transplant kidney disease. Pegcetacoplan showed favourable safety and...
PR Newswire
04/12/2025

New Leqembi-data presented at CTAD 2025 suggests potential to delay disease…

Real-world data from different clinics and countries were also presented at the congress, demonstrating continued clinical benefit with lecanemab treatment and a safety profile consistent with the phase 3 Clarity AD study. Real-world data from different clinics and countries were also presented at the congress, demonstrating continued clinical benefit with lecanemab treatment and a safety profile consistent with the phase 3 Clarity AD study. The presentations in summary: Estimating the...
PR Newswire
04/12/2025

With Child Deaths Projected to Rise for the First Time This Century, Gates…

In 2024, 4.6 million children died before their 5th birthday. According to modeling in the report, conducted by the Institute for Health Metrics and Evaluation (IHME), that number is projected to rise by just over 200,000—to an estimated 4.8 million children this year. At the same time, global development assistance for health fell sharply this year—26.9% below 2024 levels. Beyond this year's drastic funding cuts, countries face mounting debt, fragile health systems, and the risk of losing…
PR Newswire
04/12/2025

AI-Driven Personalized Nutrition and Wellness Solutions Market worth USD…

Growing concerns about lifestyle-related diseases, rising healthcare costs, and demand for preventive health solutions further strengthen market adoption. As individuals seek personalized guidance at scale and as enterprises embrace data-driven wellness programs the AI-driven nutrition and wellness ecosystem has become a strategic priority for public and private stakeholders. Growing concerns about lifestyle-related diseases, rising healthcare costs, and demand for preventive health solutions...
PR Newswire
04/12/2025

Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast…

Hemophilia A Market Summary Hemophilia A Market Summary Discover the new hemophilia A treatment @Hemophilia A Treatment Market Key Factors Driving the Growth of the Hemophilia A Market Rising Hemophilia A Target Patient Pool The diagnosed prevalence of Hemophilia A is expected to rise from 49K in 2024 to 50K by 2034. Improved diagnostic capabilities and increased disease awareness mainly drive this increase in cases. Advancements in Gene Therapy Gene...
PR Newswire
03/12/2025

HIV Therapeutics Market to Reach USD 57.56 Billion by 2033 as Long-Acting…

Buy This Report with Year-End Offer (Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer): https://www.datamintelligence.com/buy-now-page?report=hiv-therapeutics-market Buy This Report with Year-End Offer( Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer):https://www.datamintelligence.com/buy-now-page?report=hiv-therapeutics-market Long-Acting ART, Ultra-Potent INSTIs & Pipeline Innovation Driving a New Era in HIV...
PR Newswire
03/12/2025

Dyspnea Treatment Market to Reach $7,346.25 Million by 2027 in the short run and…

Request Sample of the Report on Dyspnea treatment Market Forecast 2034 – https://www.alliedmarketresearch.com/request-sample/A273997 Request Sample of the Report on Dyspnea treatment Market Forecast 2034 –https://www.alliedmarketresearch.com/request-sample/A273997 Market Introduction The dyspnea treatment market encompasses a broad range of therapeutic solutions designed to manage and relieve shortness of breath associated with respiratory and cardiovascular conditions...
PR Newswire
03/12/2025

Wingderm® Announces MDR Certification for Renuva 1550nm Non-Ablative Fractional…

Renuva utilizes fractional photothermolysis technology, delivering controlled energy into micro-areas of the skin while preserving surrounding tissue. This approach aims to enhance the skin's appearance, supporting a comfortable and minimally interruptive beauty experience. Renuva is designed for professional settings and to allow clients to resume their daily activities with minimal interruption. Moreover, Renuva procedures can be adjusted according to professional guidance for safe operation…
PR Newswire
03/12/2025

Preclinical Imaging Market worth $4.39 billion by 2030 | MarketsandMarkets™

Preclinical Imaging Market Size & Forecast: Preclinical Imaging Market Size & Forecast: Preclinical Imaging Market Trends & Insights: Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=841 In vivo preclinical imaging involves the visualization of animal models required during life science research studies. This is particularly important to academic researchers and those involved in drug development activities, prior to human trials...
PR Newswire
03/12/2025
Altri  Comunicati